183 related articles for article (PubMed ID: 29168788)
1. Microtubule Depolymerization by Kinase Inhibitors: Unexpected Findings of Dual Inhibitors.
Tanabe K
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29168788
[TBL] [Abstract][Full Text] [Related]
2. Comparison of cancer cell survival triggered by microtubule damage after turning Dyrk1B kinase on and off.
Li L; Liu Y; Zhang Q; Zhou H; Zhang Y; Yan B
ACS Chem Biol; 2014 Mar; 9(3):731-42. PubMed ID: 24377315
[TBL] [Abstract][Full Text] [Related]
3. Tivantinib induces G2/M arrest and apoptosis by disrupting tubulin polymerization in hepatocellular carcinoma.
Xiang Q; Zhen Z; Deng DY; Wang J; Chen Y; Li J; Zhang Y; Wang F; Chen N; Chen H; Chen Y
J Exp Clin Cancer Res; 2015 Oct; 34():118. PubMed ID: 26458953
[TBL] [Abstract][Full Text] [Related]
4. The design, synthesis and biological evaluation of conformationally restricted 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multi-targeted receptor tyrosine kinase and microtubule inhibitors as potential antitumor agents.
Zhang X; Raghavan S; Ihnat M; Hamel E; Zammiello C; Bastian A; Mooberry SL; Gangjee A
Bioorg Med Chem; 2015 May; 23(10):2408-23. PubMed ID: 25882519
[TBL] [Abstract][Full Text] [Related]
5. Changes in cell morphology guide identification of tubulin as the off-target for protein kinase inhibitors.
Hoque M; Abbassi RH; Froio D; Man J; Johns TG; Stringer BW; Day BW; Pajic M; Kassiou M; Munoz L
Pharmacol Res; 2018 Aug; 134():166-178. PubMed ID: 29944980
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological inhibition of LIM kinase stabilizes microtubules and inhibits neoplastic growth.
Prudent R; Vassal-Stermann E; Nguyen CH; Pillet C; Martinez A; Prunier C; Barette C; Soleilhac E; Filhol O; Beghin A; Valdameri G; Honoré S; Aci-Sèche S; Grierson D; Antonipillai J; Li R; Di Pietro A; Dumontet C; Braguer D; Florent JC; Knapp S; Bernard O; Lafanechère L
Cancer Res; 2012 Sep; 72(17):4429-39. PubMed ID: 22761334
[TBL] [Abstract][Full Text] [Related]
7. Peptide inhibitors of the anaphase promoting-complex that cause sensitivity to microtubule poison.
Schuyler SC; Wu YO; Chen HY; Ding YS; Lin CJ; Chu YT; Chen TC; Liao L; Tsai WW; Huang A; Wang LI; Liao TW; Jhuo JH; Cheng V
PLoS One; 2018; 13(6):e0198930. PubMed ID: 29883473
[TBL] [Abstract][Full Text] [Related]
8. Microtubule Targeting Agents as Cancer Chemotherapeutics: An Overview of Molecular Hybrids as Stabilizing and Destabilizing Agents.
Tangutur AD; Kumar D; Krishna KV; Kantevari S
Curr Top Med Chem; 2017; 17(22):2523-2537. PubMed ID: 28056738
[TBL] [Abstract][Full Text] [Related]
9. Miniaturization and validation of a sensitive multiparametric cell-based assay for the concomitant detection of microtubule-destabilizing and microtubule-stabilizing agents.
Vassal E; Barette C; Fonrose X; Dupont R; Sans-Soleilhac E; Lafanechère L
J Biomol Screen; 2006 Jun; 11(4):377-89. PubMed ID: 16751334
[TBL] [Abstract][Full Text] [Related]
10. G protein betagamma subunits interact with alphabeta- and gamma-tubulin and play a role in microtubule assembly in PC12 cells.
Montoya V; Gutierrez C; Najera O; Leony D; Varela-Ramirez A; Popova J; Rasenick MM; Das S; Roychowdhury S
Cell Motil Cytoskeleton; 2007 Dec; 64(12):936-50. PubMed ID: 17705289
[TBL] [Abstract][Full Text] [Related]
11. Control of microtubule organization and dynamics: two ends in the limelight.
Akhmanova A; Steinmetz MO
Nat Rev Mol Cell Biol; 2015 Dec; 16(12):711-26. PubMed ID: 26562752
[TBL] [Abstract][Full Text] [Related]
12. Microtubules depolymerization caused by the CK1 inhibitor IC261 may be not mediated by CK1 blockage.
Stöter M; Krüger M; Banting G; Henne-Bruns D; Knippschild U
PLoS One; 2014; 9(6):e100090. PubMed ID: 24937750
[TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis by the garlic-derived compound S-allylmercaptocysteine (SAMC) is associated with microtubule depolymerization and c-Jun NH(2)-terminal kinase 1 activation.
Xiao D; Pinto JT; Soh JW; Deguchi A; Gundersen GG; Palazzo AF; Yoon JT; Shirin H; Weinstein IB
Cancer Res; 2003 Oct; 63(20):6825-37. PubMed ID: 14583480
[TBL] [Abstract][Full Text] [Related]
14. Microtubule-targeting agents are clinically successful due to both mitotic and interphase impairment of microtubule function.
Field JJ; Kanakkanthara A; Miller JH
Bioorg Med Chem; 2014 Sep; 22(18):5050-9. PubMed ID: 24650703
[TBL] [Abstract][Full Text] [Related]
15. Thymoquinone inhibits microtubule polymerization by tubulin binding and causes mitotic arrest following apoptosis in A549 cells.
Acharya BR; Chatterjee A; Ganguli A; Bhattacharya S; Chakrabarti G
Biochimie; 2014 Feb; 97():78-91. PubMed ID: 24113316
[TBL] [Abstract][Full Text] [Related]
16. [Inhibitors of microtubule polymerization- new natural compounds as potential anti-cancer drugs].
Rogalska A; Miśkiewicz K; Marczak A
Postepy Hig Med Dosw (Online); 2015 May; 69():571-85. PubMed ID: 25983296
[TBL] [Abstract][Full Text] [Related]
17. p53 does not control the spindle assembly cell cycle checkpoint but mediates G1 arrest in response to disruption of microtubule system.
Sablina AA; Agapova LS; Chumakov PM; Kopnin BP
Cell Biol Int; 1999; 23(5):323-34. PubMed ID: 10579898
[TBL] [Abstract][Full Text] [Related]
18. Recent developments in tubulin polymerization inhibitors: An overview.
Kaur R; Kaur G; Gill RK; Soni R; Bariwal J
Eur J Med Chem; 2014 Nov; 87():89-124. PubMed ID: 25240869
[TBL] [Abstract][Full Text] [Related]
19. Structure-based virtual screening of novel tubulin inhibitors and their characterization as anti-mitotic agents.
Kim ND; Park ES; Kim YH; Moon SK; Lee SS; Ahn SK; Yu DY; No KT; Kim KH
Bioorg Med Chem; 2010 Oct; 18(19):7092-100. PubMed ID: 20810285
[TBL] [Abstract][Full Text] [Related]
20. c-Jun N-terminal kinase mediates microtubule-depolymerizing agent-induced microtubule depolymerization and G2/M arrest in MCF-7 breast cancer cells.
Chen J; Sun WL; Wasylyk B; Wang YP; Zheng H
Anticancer Drugs; 2012 Jan; 23(1):98-107. PubMed ID: 21968419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
